Medpace Holdings (MEDP) Capital Expenditures (2015 - 2026)

Medpace Holdings (MEDP) has reported Capital Expenditures for 12 consecutive years, with $23.9 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Capital Expenditures rose 291.15% year-over-year to $23.9 million; the trailing twelve-month figure through Jun 2026 stood at $46.0 million (up 34.09% YoY), and the FY2025 full-year result was $31.4 million, down 14.21% from the prior year.
• Capital Expenditures climbed to $23.9 million in Q2 2026 per MEDP's latest filing, from $6.8 million in the prior quarter.
• Across five years, Capital Expenditures topped out at $23.9 million in Q2 2026 and bottomed at $4.5 million in Q4 2025.
• Historically, Capital Expenditures has averaged $9.6 million across 5 years, with a median of $9.2 million in 2022.
• The sharpest annual moves came in 2025 and 2026: Capital Expenditures slumped 52.51% in 2025, then soared 291.15% in 2026.
• Over 5 years, Capital Expenditures stood at $9.2 million in 2022, then advanced by 8.04% to $10.0 million in 2023, then declined by 23.46% to $7.6 million in 2024, then plunged by 40.65% to $4.5 million in 2025, then soared by 427.14% to $23.9 million in 2026.
• According to Business Quant data, Capital Expenditures over the past three periods registered $23.9 million, $6.8 million, and $4.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.